Health Condition 1: L509- Urticaria, unspecified
Conditions
Interventions
Intervention1: Individualised homoeopathic medicine in the treatment of chronic urticaria: It s a single arm study where the sample size is 45 and each subject will be given individualised homoeopathi
Sponsors
Chaithali K S
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects who are willing to participate voluntarily in the study and sign the written informed consent. 2. Subjects aged 20 to 40 years. 3. Subjects who are diagnosed with Chronic Urticaria based on The International European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GALEN), the European Dermatology Forum (EDF); and the World Allergy Organization (WAO): EAACI/ GALEN/ EDF/ WAO guideline for diagnosis of urticaria.
Exclusion criteria
Exclusion criteria: 1. Subjects who are under medication or any therapy from other systems of medicine for the same complaint. 2. Pregnant and lactating women. 3. Subjects suffering from Chronic Urticaria associated with other systemic diseases such as Urticaria Vasculitis, Liver Cirrhosis, Mastocytosis and Systemic Lupus Erythematosus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RECOVERED: Subjects with a complete relief in the clinical symptoms, with a general sense of well-being. Improvement in Urticaria Control Test score (UCT = 16). IMPROVED: Subjects who are symptomatically better, with slight improvement in Urticaria Control Test score (UCT = 12-15).Timepoint: Follow up will be done once in 15 days for initial 3 months and followed by once in a month for remaining 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Chaithali K S
Government
Outcome results
None listed